Clinical Trial Update: Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a Phase 1/2 clinical trial of SCT200 for advanced esophageal squamous cell carcinoma, focusing on safety and efficacy, with the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• SCT200

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Esophageal Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN